Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-20T07:00:14.877Z Has data issue: false hasContentIssue false
  • English
  • Français

Tuberculosis in Prison: Balancing Justice and Public Health

Published online by Cambridge University Press:  01 January 2021

Robert B. Greifinger ,
Nancy J. Heywood  and
Jordan B. Glaser
Get access Rights & Permissions [Opens in a new window]

Extract

During the mid-nineteenth century the annual tuberculosis (TB) mortality in the penitentiaries at Auburn, N.Y., Boston, and Philadelphia exceeded 10 percent of the inmate population. At the beginning of the sanatorium era, 80 percent of the prison deaths were attributed to TB. As the mountain air was “commonly known” to be healthful, the first prison sanatorium was opened in the mountains near Dannemora, N.Y. in 1904. It served to isolate contagious prison inmates until the advent of effective chemotherapy for the disease in the 1950’s. Early antibiotic therapy for TB was such a great success that the public health aspects of TB in prisons remained dormant for the next 40 years.

In 1991, a correctional officer from Auburn Correctional Facility in Auburn, New York died as a result of multidrug-resistant TB. He had been posted to care for hospitalized patients, from whom he acquired his disease. This death, and the transmission of TB infection to health care workers in the same hospital, brought the nature and extent of modern inmate medical care into finer focus.

Type
Article
Information
Journal of Law, Medicine & Ethics , Volume 21 , Issue 3-4 , Fall Winter 1993 , pp. 332 - 341
Copyright
Copyright © American Society of Law, Medicine and Ethics 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dubos, Rene, The White Plague (New Brunswick: Rutgers University Press, 199).Google Scholar
Clinton Prison at Dannemora (Plattsburgh: Clinton County Historical Museum, 1987); Rowell, M.A., “Tuberculosis Work at Clinton Prison,” Adirondack News, May 25, 1907.Google Scholar
Osborn, June E., Rogers, David E., HIV Disease in Correctional Facilities (Washington, D.C., National Commission on AIDS, March 1991).Google Scholar
Centers for Disease Control, “National Action Plan to Combat Multidrug-Resistant Tuberculosis,” Morbidity and Mortality Weekly Report, 41 (1992): 5–71.Google Scholar
Dooley, Samuel W. et al., “Multidrug-Resistant Tuberculosis,” Annals of Internal Medicine, 117 (1992): 257–258.CrossRefGoogle Scholar
Estelle v. Gamble, 429 U.S. 97 (1976); Anno, B. Jaye, Prison Health Care: Guidelines for the Management of An Adequate Delivery System (Washington: National Institute of Corrections, U.S. Department of Justice, 1991): 1–52.Google Scholar
Id., pp 53–69.Google Scholar
Weisbuch, Jonathan B., “The New Responsibility for Prison Health: Working with the Public Health Community,” Journal of Prison and Jail Health 10 (1991): 3–17; Weisbuch, Jonathan B., “Public Health Professionals and Prison Health Care Needs,” American Journal of Public Health, 67 (1977): 720-722; Glaser, Jordan B., Greifinger, Robert B., “Correctional Health Care: A Public Health Opportunity,” Annals of Internal Medicine, 118 (1993): 139-45.Google Scholar
Dubler, Nancy N. et al., “Tuberculosis in the 1990's: Ethical, Legal, and Public Policy Issues in Screening, Treatment, and the Protection of Those in Congregate Facilities,” in Vladeck, Bruce C., ed., The Tuberculosis Revival: Individual Rights and Societal Obligation in a Time of AIDS (New York: United Hospital Fund, 1992); Gostin, Larry O., “Public Health Powers: The Imminence of Radical Change,” The Milbank Quarterly, 69 (1991): 268-290; Joseph, Stephen C., Dragon Within the Gates (New York: Carroll & Graf, 1992): 100.Google Scholar
Weisbuch, , American Journal of Public Health, supra note 8.Google Scholar
Bureau of Justice Statistics, Correctional Populations in the United States 1990, NCJ-134946 (Washington, DC: Department of Justice, July 1992): 5.Google Scholar
Id., p. 52.Google Scholar
Id., p. 6.Google Scholar
Id., p. 6.Google Scholar
Camp, George, Camp, Camille, The Corrections Yearbook: 1993 (South Salem, N.Y.: Criminal Justice Institute, 1993): 16–17.Google Scholar
Bureau of Justice Statistics, Prisoners in 1990 (Washington, D.C.: U.S. Department of Justice, 1991); Bureau of Justice Statistics, Jail Inmates, 1990 (Washington, D.C.: U.S. Department of Justice, 1991).Google Scholar
Camp, George, Camp, Camille, Supra note 15 at 35.Google Scholar
Bureau of Justice Statistics, Prisoners in 1992 (Washington D.C., U.S. Department of Justice, 1993).Google Scholar
Austin, J., McVey, A.D., The 1989 NCCD Prison Population Forecast: The Impact of the War on Drugs (San Francisco: The National Council on Crime and Delinquency, 1989).Google Scholar
Bureau of Justice Statistics, Federal Sentencing in Transition, 1986–1990 (Washington, D.C.: U.S. Department of Justice, 1992).Google Scholar
Bureau of Justice Statistics, Drugs and Crime Facts 1991 (Washington, D.C.: U.S. Department of Justice, 1992).Google Scholar
Bureau of Justice Statistics, Drugs and Crime Facts 1991 (Washington, D.C.: U.S. Department of Justice, 1992).Google Scholar
Bureau of Justice Statistics, supra note 11.Google Scholar
Bureau of Justice Statistics, supra note 18.Google Scholar
American College of Physicians, National Commission on Correctional Health Care, and American Correctional Health Services Association, “The Crisis in Correctional Health Care: The Impact of the National Drug Control Strategy on Correctional Health Services,” Annals of Internal Medicine, 117(1992): 71–78; Novick, Lloyd F. et al., “Health Status of the New York City Prison Population,” Medical Care, 15 (1977): 205-216.Google Scholar
Moini, Saira, Hammett, Theodore M., 1989 Update: AIDS in Correctional Facilities, (Washington, D.C.: National Institute of Justice, 1990); Caroline Wolf Harlow, Bureau of Justice Statistics, HIV in U.S. Prisons and Jails (Washington, D.C.: U.S. Department of Justice, 1993).Google Scholar
Hammett, T.M. et al., “1992 Update AIDS in Correctional Facilities,” National Institute of Justice, June 16, 1993 Draft.Google Scholar
Harlow, , Supra note 26.Google Scholar
Hammett, , Supra note 27.Google Scholar
American College of Physicians, supra note 25.Google Scholar
Mikl, Jaromir, Smith, Perry F., Greifinger, Robert B., HIV Seroprevalence Among New York State Prison Entrants, IXth International Conference on AIDS, Berlin, abstract no. PO-C21-3108, June 6-11, 1993.Google Scholar
Mikl, Jaromir et al., “HIV Seroprevalence of Male Inmates Entering the New York State Correctional System,” American Public Health Association Poster Presentation, 1991; Smith, Perry F. et al., “HIV Infection among Women Entering the New York State Correctional System,” American Journal of Public Health, 81 supp (1991): 35–40.Google Scholar
Glaser, Jordan B., Greifinger, Robert B., Supra note 8.Google Scholar
Braun, Miles M. et al., “Increasing Incidence of Tuberculosis in a Prison Inmate Population,” Journal of the American Medical Association, 261 (1989): 393–397; Abeles, A. et al., “The Large City Prison: A Reservoir of Tuberculosis,” American Review of Respiratory Disease, 101 (1970): 706-709; King, Lambert, Geis, G., “Tuberculosis Transmission in a Large Urban Jail,” Journal of the American Medical Association, 137 (1977): 791-792.CrossRefGoogle Scholar
Snider, Dixie E. Jr, Hutton, Mary D., “Tuberculosis in Correctional Institutions,” Journal of the American Medical Association, 261 (1989): 436–437; Barnes, Peter F. et al., “Tuber culosis in Patients with Immunodeficiency Virus Infection,” New England Journal of Medicine, 324 (1991): 1644-1650; Centers for Disease Control, “Prevention and Control of Tuberculosis in Correctional Institutions: Recommendations of the Advisory Committee for the Elimination of Tuberculosis,” Morbidity and Mortality Weekly Report, 38 (1989): 313-320, 325; Centers for Disease Control, “Tuberculosis and Human Immunodeficiency Virus Infection: Recommendations of the Advisory Committee for the Elimination of Tuberculosis,” Morbidity and Mortality Weekly Report, 38 (1989): 236-238, 243-250.CrossRefGoogle Scholar
Centers for Disease Control, “Nosocomial Transmission of Multidrug-Resistant Tuberculosis Among HIV-infected Persons—Florida and New York, 1988–1991,” Morbidity and Mortality Weekly Report, 40 (1991): 585–91.Google Scholar
Selwyn, Peter A. et al., “A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection,” New England Journal of Medicine, 320 (1989): 545–550.CrossRefGoogle Scholar
Centers for Disease Control, “Transmission of Multidrug-Resistant Tuberculosis Among Immunocompromised Persons in a Correctional System—New York, 1991,” Morbidity and Mortality Weekly Report, 41 (1992): 507–509.Google Scholar
Greifinger, Robert B., “Tuberculosis Behind Bars,” in Vladeck, Bruce C., ed., supra note 9.Google Scholar
Brudney, Karen, Dobkin, Jay, “Resurgent Tuberculosis in New York City,” American Review of Respiratory Disease, 144 (1991): 745–749; Snider, Dixie E., Roper, William L., “The New Tuberculosis,” New England Journal of Medicine, 41 (1992): 1-11; Torres, Ramon A. et al., “Human Immunodeficiency Virus Infection Among Homeless Men in a New York City Shelter: Association with Mycobacterium Tuberculosis Infection,” Archives of Internal Medicine, 150 (1990): 2030-2036; Centers for Disease Control, “Tuberculosis Outbreak Among Persons in a Residential Facility for HIV-infected Persons—San Francisco,” Morbidity and Mortality Weekly Report, 40 (1991): 649-52; Centers for Disease Control, “Nosocomial Transmission of Multidrug-Resistant Tuberculosis Among HIV-infected Persons—Florida and New York, 1988–1991,” Morbidity and Mortality Weekly Report, 40 (1991): 586-591; Edlin, Brian R. et al., “An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency Syndrome,” New England Journal of Medicine, 326 (1991): 231-235; Pearson, Michele L. et al., “Nosocomial Transmission of Multidrug-Resistant Mycobacterium Tuberculosis: A Risk to Patients and Health Care Workers,” Annals of Internal Medicine, 117 (1992): 191-196; Fischl, Margaret A. et al., “An Outbreak of Tuberculosis Caused by Multiple-Drug-resistant Tubercle Bacilli among Patients with HIV Infection,” Annals of Internal Medicine, 117 (1992): 177-183.CrossRefGoogle Scholar
Fischl, Margaret A., “Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli,” Annals of Internal Medicine 117 (1992): 184–190.CrossRefGoogle Scholar
Bellin, Eran Y., Fletcher, David D., Safyer, Steven M., “Association of Tuberculosis Infection with Increased Time in or Admission to the New York City Jail System,” JAMA, 269 (1993): 2228–2231.CrossRefGoogle Scholar
Rosenberg, Charles E., The Care of Strangers: The Rise of America's Hospital System (New York: Basic Books, 1987): 309.Google Scholar
Centers for Disease Control, Control of Tuberculosis in Correctional Facilities: A Guide for Health Care Workers (Washington, D.C.: U.S. Department of Health and Human Services, 1992).Google Scholar
Sbarbaro, John A., “Skin Testing in the Diagnosis of Tuberculosis,” Seminars in Respiratory Infections, 1 (1986): 234–238; Sbarbaro, John A., “Tuberculin Test: A Re-emphasis on Clinical Judgement,” American Review of Respiratory Disease, 132 (1985): 177-178; Centers for Disease Control, “Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Settings, with Special Focus on HIV-Related Issues,” Morbidity and Mortality Weekly Reports, 39 (1990): 1-28.Google Scholar
H. Von Holden v. Chapman, 87 A.D.2d66, 450 N.Y.S. 2d 623 (4th Dept. 1982).Google Scholar
Jacobson v. Mass., 197 U.S. 11 (1905).CrossRefGoogle Scholar
Lareau v. Manson, 651 F.2d 96,109 (2nd Cir. 1981)CrossRefGoogle Scholar
Bell v. Wolfish, 441 U.S. 520 at 535 (1979).Google Scholar
Hutte v. Finney, 437 U.S. 678, at 685 (1978).CrossRefGoogle Scholar
Lareau v. Manson, supra note 48, at p. 109, quoting the District Court's decision at 507 F.Supp at 1195.Google Scholar
Id. quoting Estelle v. Gamble 429 U.S. 97, 106 (1976).Google Scholar
Austin v. Pennsylvania Department of Correction, 1992 WL 277511 (E.D.Pa.)Google Scholar
Turner v. Safley, 482 U.S. 78, 89–90, (1987).CrossRefGoogle Scholar
Ballard v. Woodard, 641 F.Supp 432 (W.D.N.C. 1986).Google Scholar
Id. at p. 436, quoting Jones v. North Carolina Prisoner's Union, Inc., 433 U.S. 119, 129 (1977) and Pell v. Procunier, 417 U.S. 817, 822 (1974).Google Scholar
Zaire v. Dalsheim, 698 F.Supp. 57 (S.D.N.Y. 1988) affirmed without opinion 904 F.2d 33 (2nd Cir. 1990).Google Scholar
Id. at p. 59, quoting Estelle v. Gamble, 429 U.S. 97, 105–106 (1976).Google Scholar
Id. at p. 59, quoting Williams v. Bennett, 689 F.2d 1370, 1380 (11th Cir. 1982), cert. denied, 464 U.S. 932 (1983); Wright v. El Paso County Jail, 642 F.2d 134, 136 (5th Cir. 1981).Google Scholar
Id. at p. 60.Google Scholar
Turner v. Safley, supra note 54, at p. 89.Google Scholar
Washington v. Harper, 494 U.S. 210 (1990).Google Scholar
National Treasury Employees Union v. Von Raab, 816 F.2d 170 (5th Cir. 1987), affirmed in part, vacated in part 489 U.S. 656 (1989); Skinner v. Railway Labor Executives Association, 489 U.S. 602 (1989).Google Scholar
Schmerber v. California, 384 U.S. 757, 761 (1966).Google Scholar
Turner v. Safley, supra note 54, at p. 89.Google Scholar
Dunn v. White, 880 F.2d 1188 (10 Cir. 1989). Cert. denied 493 U.S. 1059 (1990).Google Scholar
Centers for Disease Control, “Screening for Tuberculosis Infection in High Risk Populations, and The Use of Preventive Therapy in the United States: Recommendations of the Advisory Committee for Elimination of Tuberculosis,” Morbidity and Mortality Weekly Report, 39 (1990); Jordan, Theresa J. et al., “Isoniazid as Preventive Therapy in HIV-infected Intravenous Drug Abusers,” Journal of the American Medical Association, 265 (1991): 2987-2991.Google Scholar
Kopanoff, Donald E., Snider, Dixie E., Caras, Gus J., “Isoniazid-Related Hepatitis,” American Review of Respiratory Disease, 117 (1978): 991–1001; Taylor, William C., Aronson, Mark D., Delbanco, Thomas L., “Should Young Adults with a Positive Tuberculin Test Take Isoniazid?” Annals of Internal Medicine, 94 (1981): 808-813; Israel, Harold L., Gottlieb, Jonathan E., Maddrey, Willis C., “Perspective: Preventive Isoniazid Therapy and the Liver,” Chest, 101 (1992): 1298-1301.Google Scholar
Selwyn, Peter A. et al., “High Risk of Active Tuberculosis in HIV-infected Drug Users with Cutaneous Anergy,” Journal of the American Medical Association, 268 (1992): 504–509.CrossRefGoogle Scholar
Hill v. Marshall, 962 F.2d 1209 (6th Cir. 1992).Google Scholar
Centers for Disease Control, supra note 67; Sbarbaro, John A., “The Patient-Physician Relationship: Compliance Revisited,” Annals of Allergy, 64 (1990): 325–332; Sbarbaro, John A., “Compliance: Inducements and Enforcements,” Chest, 76 Supp (1979): 750-756.Google Scholar
Graham, Neil M.H. et al., “Prevalence of Tuberculin Positivity and Skin Test Anergy in HIV-1-Seropositive and – Seronegative Intravenous Drug Users,” Journal of the American Medical Association, 267 (1992): 369–373; Huebner, Robin E., Villarino, Margarita F., Snider, Dixie E., “Tuberculin Skin Testing and the HIV Epidemic,” Journal of the American Medical Association, 267 (1992): 409-410.CrossRefGoogle Scholar
Centers for Disease Control, “Tuberculosis and Human Immunodeficiency Virus Infection,” supra note 35.Google Scholar
Dunn v. White, 880 F.2d 1188 (10th Cir. 1989).Google Scholar
Ryan, Frank, The Forgotten Plague, How the Battle Against Tuberculosis was Won—and Lost (New York: Little, Brown and Company, 1993): 413.Google Scholar
Id, p. 417.Google Scholar